Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of autism spectrum disorders

Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder; and pharmaceutical preparations containing tasimelteon for use in the treatment of circadian rhythm sleep disorders; pharmaceutical preparations containing tasimelteon for use in the treatment of Smith-Magenis Syndrome

Pharmaceutical preparations, containing tasimelteon, for use in the treatment of jet lag disorder; and pharmaceutical preparations containing tasimelteon for use in the treatment of autism spectrum disorders

Pharmaceutical preparations for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, and diseases and disorders having a central nervous system manifestation

Pharmaceutical preparations containing tasimelteon for use in the treatment of Autism Spectrum Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Jet Lag Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of depression; Pharmaceutical preparations containing tasimelteon for use in the treatment of Major Depressive...

Pharmaceutical preparations, containing tasimelteon, for use in the treatment of Smith-Magenis Syndrome; Pharmaceutical preparations, containing tasimelteon, for use in the treatment of sleep disorders

Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; and pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder

Pharmaceutical preparations, containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, and diseases and disorders having a central nervous system manifestation

Pharmaceutical preparations, in liquid form and containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, diseases and disorders having a central nervous system manifestation, diseases and disorders of the circadian rhythm, diseases and disorders having an impact on circadian rhythm, and diseases and disorders having a circadian rhythm manifestation

Pharmaceutical preparations, in liquid form and containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, diseases and disorders having a central nervous system manifestation, diseases and disorders of the circadian rhythm, diseases and disorders having an impact on circadian rhythm, and diseases and disorders having a circadian rhythm manifestation

Insurance services, namely, insurance eligibility review and verification and consultation in the healthcare industry; providing a database featuring information about patient reimbursement and insurance coverage for pharmaceuticals; providing health insurance claims negotiation and appeal services; and providing information about healthcare insurance plans, namely, identifying insurance options to cover prescription drug therapy

Insurance services, namely, insurance eligibility review and verification and consultation in the healthcare industry; providing a database featuring information about patient reimbursement and insurance coverage for pharmaceuticals; providing health insurance claims negotiation and appeal services; providing information about healthcare insurance plans, namely, identifying insurance options to cover prescription drug therapy; and patient assistance programs, namely, providing financial assis...